Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
SkinJect develops a dissolvable microneedle patch delivery system to treat non-melanoma skin cancers such as basal cell carcinoma by stimulating an immune response against the disease. The device combines FDA-approved microneedles and chemotherapy cargo for topical skin cancer treatment.
0 investors
Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.
0 investors
0 investors
SLAM BioTherapeutics is a preclinical-stage biotech developing first-in-class antibody-drug conjugates (ADCs) and bispecific monoclonal antibodies targeting the SLAM family of immune receptors (notably CD84/SLAMF5) for blood cancers such as MDS, AML, CTCL, and follicular lymphoma. Its lead asset SLM124 is planned to enter Phase 1 clinical trials in 2026, serving patients with hard-to-treat hematologic malignancies.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Solaris Endovascular develops covered stent grafts and drug-eluting technology for treating dialysis access and peripheral artery disease (PAD) in patients with end-stage kidney disease. Its electrospinning PTFE covered stent grafts target vascular care for hemodialysis access and PAD, serving physicians and distributors.
0 investors
0 investors
0 investors
0 investors
0 investors
SOLTÉGO is a bio-cosmetics company developing skin care products aimed at protecting and repairing skin from sun-induced damage. Its team includes chemists, formulators, skin pharmacologists, and cosmetic safety experts.
0 investors
0 investors
Sonablate Corp. develops HIFU (high-intensity focused ultrasound) technology for focal therapy, initially applied to treating prostate disease as an alternative to conventional treatments. Its systems are used by physicians, with plans to address a broader range of medical conditions.
0 investors
0 investors
A neuroscience company developing medical solutions based on brain imaging and neurological research for clinical and research applications.
0 investors